Search Results 41-50 of 16554 for Inhibition

  1. C1 Esterase Inhibitor Recombinant (Intravenous Route) Side Effects - Mayo Clinic

    Incidence not known · Cough · difficulty swallowing · dizziness · fast heartbeat · hives, itching, or skin rash · pains in the chest, groin, or legs, especially ...

  2. Anti-Inhibitor Coagulant Complex (Intravenous Route) Side Effects - Mayo Clinic

    Incidence not known · Burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings · chest pain. discomfort, or tightness · cough ...

  3. Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL - Mayo Clinic

    TP-0903 has shown potent inhibition of AXL kinase and other TAM family members in a biochemical kinase assay. TP-0903 demonstrates corresponding activity in ...

  4. Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults - Mayo Clinic

    About this study. This phase III trial compares the effect of usual treatment of chemotherapy and steroids and a tyrosine kinase inhibitor (TKI) to the same ...

  5. Breast cancer chemoprevention: Drugs that reduce risk - Mayo Clinic

    Aromatase inhibitors aren't associated with an increased risk of blood clots or uterine cancer, as tamoxifen and raloxifene are. Because aromatase inhibitors ...

  6. Overview - Heart Failure and Transplantation: Paul C. Tang - Mayo Clinic Research

    This image from our lab shows Nrf2 nuclear translocation in donor hearts after histone deacetylase inhibition. Purple and pink cultured cells depict ...

  7. C1 Esterase Inhibitor Recombinant (Intravenous Route) Proper Use - Mayo Clinic

    For injection dosage form: For hereditary angioedema: Adults and teenagers—Dose is based on body weight and must be determined by a doctor. The usual dose is 50 ...

  8. Study of Bromodomain and Extra-Terminal Protein (BET) Inhibitor RO6870810 as Mono- and Combination Therapy in Advanced Multiple Myeloma - Mayo Clinic

    Study of Bromodomain and Extra-Terminal Protein (BET) Inhibitor RO6870810 as Mono- and Combination Therapy in Advanced Multiple Myeloma. Print details. Share ...

  9. Immune mediated diabetes due to PD 1 inhibitors - Mayo Clinic

    The purpose of this study is to identify immune mediated diabetes in patients treated with PD 1 inhibitors, and characterizing its clinical course, laboratory ...

  10. Development of PARP Inhibitors and DDR Modifiers To Treat Ovarian Cancer - Anticancer Drug Action Laboratory - Mayo Clinic Research

    Dr. Kaufmann and his team in the Anticancer Drug Action Lab at Mayo Clinic are studying the susceptibility of HR-deficient cancer cells to PARP inhibitors ...